SPOTLIGHT: Chantix scrips drop 5% on FDA alert

Prescriptions for Pfizer's stop-smoking drug Chantix dropped 5 percent last week after the FDA called it "increasingly likely" that there is a link between use of the drug and various neuro-psychiatric symptoms, including suicidal behavior. Report